Cancer clinical trials in the region Occitanie
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Prostate cancer
#NCT04585750
Metastatic Castration-resistant
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
PMV Pharmaceuticals, Inc
Phase 2
Breast cancer
#NCT04585750
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
PMV Pharmaceuticals, Inc
Phase 2
Lung cancer
#NCT04585750
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
PMV Pharmaceuticals, Inc
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04585750
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
PMV Pharmaceuticals, Inc
Phase 2
Pancreas cancer
#NCT04570943
Adenocarcinoma
Locally Advanced
Systemic Treatment-Naive
Systemic Treatment-Naive
None
6 main criterias to confirm
Institut du cancer de Montpellier (Montpellier), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Institut de cancérologie du Gard (Nîmes)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Lung cancer
#NCT04526782
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
BRAF
Surgery
Chemotherapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
1
ALK
EGFR
ROS-1
Targeted therapy
Targeted therapy
10 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier), Institut Sainte Catherine (Avignon), Centre Hospitalier François Mitterrand de Pau (Pau)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04268121
Neuroendocrine tumor
Localized
Systemic Treatment-Naive
None
5 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Colon cancer
Rectal cancer
#NCT04262687
Metastatic
MSS
Systemic Treatment-Naive
Surgery
Chemotherapy
None
1
MSI/dMMR
Immunotherapy
Immunotherapy
8 main criterias to confirm
Centre Hospitalier de Béziers (Béziers), Centre Hospitalier de Perpignan (Perpignan), Centre Hospitalier Universitaire de Nîmes (Nîmes), Institut Sainte Catherine (Avignon), Centre Hospitalier d'Avignon (Avignon) (and 3 more...)
Fédération Francophone de Cancérologie Digestive
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
#NCT04116541
Locally Advanced
Metastatic
Metastatic Castration-resistant
ALK
BRAF
EGFR
FGFR
MET
NTRK-1/2/3
RET
ROS-1
SMAD4
Other mutation
1
2
3 or more
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse)
Centre Léon Bérard
Phase 2
Lung cancer
#NCT04042558
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
ALK
EGFR
ROS-1
Chemotherapy
Targeted therapy
Radiotherapy
Targeted therapy
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse)
Centre François Baclesse